2119 related articles for article (PubMed ID: 16530701)
1. Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis.
Phillips HS; Kharbanda S; Chen R; Forrest WF; Soriano RH; Wu TD; Misra A; Nigro JM; Colman H; Soroceanu L; Williams PM; Modrusan Z; Feuerstein BG; Aldape K
Cancer Cell; 2006 Mar; 9(3):157-73. PubMed ID: 16530701
[TBL] [Abstract][Full Text] [Related]
2. Genetic and molecular epidemiology of adult diffuse glioma.
Molinaro AM; Taylor JW; Wiencke JK; Wrensch MR
Nat Rev Neurol; 2019 Jul; 15(7):405-417. PubMed ID: 31227792
[TBL] [Abstract][Full Text] [Related]
3. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1.
Verhaak RG; Hoadley KA; Purdom E; Wang V; Qi Y; Wilkerson MD; Miller CR; Ding L; Golub T; Mesirov JP; Alexe G; Lawrence M; O'Kelly M; Tamayo P; Weir BA; Gabriel S; Winckler W; Gupta S; Jakkula L; Feiler HS; Hodgson JG; James CD; Sarkaria JN; Brennan C; Kahn A; Spellman PT; Wilson RK; Speed TP; Gray JW; Meyerson M; Getz G; Perou CM; Hayes DN;
Cancer Cell; 2010 Jan; 17(1):98-110. PubMed ID: 20129251
[TBL] [Abstract][Full Text] [Related]
4. The somatic genomic landscape of glioblastoma.
Brennan CW; Verhaak RG; McKenna A; Campos B; Noushmehr H; Salama SR; Zheng S; Chakravarty D; Sanborn JZ; Berman SH; Beroukhim R; Bernard B; Wu CJ; Genovese G; Shmulevich I; Barnholtz-Sloan J; Zou L; Vegesna R; Shukla SA; Ciriello G; Yung WK; Zhang W; Sougnez C; Mikkelsen T; Aldape K; Bigner DD; Van Meir EG; Prados M; Sloan A; Black KL; Eschbacher J; Finocchiaro G; Friedman W; Andrews DW; Guha A; Iacocca M; O'Neill BP; Foltz G; Myers J; Weisenberger DJ; Penny R; Kucherlapati R; Perou CM; Hayes DN; Gibbs R; Marra M; Mills GB; Lander E; Spellman P; Wilson R; Sander C; Weinstein J; Meyerson M; Gabriel S; Laird PW; Haussler D; Getz G; Chin L;
Cell; 2013 Oct; 155(2):462-77. PubMed ID: 24120142
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive genomic characterization defines human glioblastoma genes and core pathways.
Cancer Genome Atlas Research Network
Nature; 2008 Oct; 455(7216):1061-8. PubMed ID: 18772890
[TBL] [Abstract][Full Text] [Related]
6. Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma.
Noushmehr H; Weisenberger DJ; Diefes K; Phillips HS; Pujara K; Berman BP; Pan F; Pelloski CE; Sulman EP; Bhat KP; Verhaak RG; Hoadley KA; Hayes DN; Perou CM; Schmidt HK; Ding L; Wilson RK; Van Den Berg D; Shen H; Bengtsson H; Neuvial P; Cope LM; Buckley J; Herman JG; Baylin SB; Laird PW; Aldape K;
Cancer Cell; 2010 May; 17(5):510-22. PubMed ID: 20399149
[TBL] [Abstract][Full Text] [Related]
7. An integrated genomic analysis of human glioblastoma multiforme.
Parsons DW; Jones S; Zhang X; Lin JC; Leary RJ; Angenendt P; Mankoo P; Carter H; Siu IM; Gallia GL; Olivi A; McLendon R; Rasheed BA; Keir S; Nikolskaya T; Nikolsky Y; Busam DA; Tekleab H; Diaz LA; Hartigan J; Smith DR; Strausberg RL; Marie SK; Shinjo SM; Yan H; Riggins GJ; Bigner DD; Karchin R; Papadopoulos N; Parmigiani G; Vogelstein B; Velculescu VE; Kinzler KW
Science; 2008 Sep; 321(5897):1807-12. PubMed ID: 18772396
[TBL] [Abstract][Full Text] [Related]
8. Mesenchymal differentiation mediated by NF-κB promotes radiation resistance in glioblastoma.
Bhat KPL; Balasubramaniyan V; Vaillant B; Ezhilarasan R; Hummelink K; Hollingsworth F; Wani K; Heathcock L; James JD; Goodman LD; Conroy S; Long L; Lelic N; Wang S; Gumin J; Raj D; Kodama Y; Raghunathan A; Olar A; Joshi K; Pelloski CE; Heimberger A; Kim SH; Cahill DP; Rao G; Den Dunnen WFA; Boddeke HWGM; Phillips HS; Nakano I; Lang FF; Colman H; Sulman EP; Aldape K
Cancer Cell; 2013 Sep; 24(3):331-46. PubMed ID: 23993863
[TBL] [Abstract][Full Text] [Related]
9. The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary.
Louis DN; Perry A; Reifenberger G; von Deimling A; Figarella-Branger D; Cavenee WK; Ohgaki H; Wiestler OD; Kleihues P; Ellison DW
Acta Neuropathol; 2016 Jun; 131(6):803-20. PubMed ID: 27157931
[TBL] [Abstract][Full Text] [Related]
10. Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma.
Patel AP; Tirosh I; Trombetta JJ; Shalek AK; Gillespie SM; Wakimoto H; Cahill DP; Nahed BV; Curry WT; Martuza RL; Louis DN; Rozenblatt-Rosen O; Suvà ML; Regev A; Bernstein BE
Science; 2014 Jun; 344(6190):1396-401. PubMed ID: 24925914
[TBL] [Abstract][Full Text] [Related]
11. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial.
Stupp R; Hegi ME; Mason WP; van den Bent MJ; Taphoorn MJ; Janzer RC; Ludwin SK; Allgeier A; Fisher B; Belanger K; Hau P; Brandes AA; Gijtenbeek J; Marosi C; Vecht CJ; Mokhtari K; Wesseling P; Villa S; Eisenhauer E; Gorlia T; Weller M; Lacombe D; Cairncross JG; Mirimanoff RO; ;
Lancet Oncol; 2009 May; 10(5):459-66. PubMed ID: 19269895
[TBL] [Abstract][Full Text] [Related]
12. Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma.
Sturm D; Witt H; Hovestadt V; Khuong-Quang DA; Jones DT; Konermann C; Pfaff E; Tönjes M; Sill M; Bender S; Kool M; Zapatka M; Becker N; Zucknick M; Hielscher T; Liu XY; Fontebasso AM; Ryzhova M; Albrecht S; Jacob K; Wolter M; Ebinger M; Schuhmann MU; van Meter T; Frühwald MC; Hauch H; Pekrun A; Radlwimmer B; Niehues T; von Komorowski G; Dürken M; Kulozik AE; Madden J; Donson A; Foreman NK; Drissi R; Fouladi M; Scheurlen W; von Deimling A; Monoranu C; Roggendorf W; Herold-Mende C; Unterberg A; Kramm CM; Felsberg J; Hartmann C; Wiestler B; Wick W; Milde T; Witt O; Lindroth AM; Schwartzentruber J; Faury D; Fleming A; Zakrzewska M; Liberski PP; Zakrzewski K; Hauser P; Garami M; Klekner A; Bognar L; Morrissy S; Cavalli F; Taylor MD; van Sluis P; Koster J; Versteeg R; Volckmann R; Mikkelsen T; Aldape K; Reifenberger G; Collins VP; Majewski J; Korshunov A; Lichter P; Plass C; Jabado N; Pfister SM
Cancer Cell; 2012 Oct; 22(4):425-37. PubMed ID: 23079654
[TBL] [Abstract][Full Text] [Related]
13. The definition of primary and secondary glioblastoma.
Ohgaki H; Kleihues P
Clin Cancer Res; 2013 Feb; 19(4):764-72. PubMed ID: 23209033
[TBL] [Abstract][Full Text] [Related]
14. Most human non-GCIMP glioblastoma subtypes evolve from a common proneural-like precursor glioma.
Ozawa T; Riester M; Cheng YK; Huse JT; Squatrito M; Helmy K; Charles N; Michor F; Holland EC
Cancer Cell; 2014 Aug; 26(2):288-300. PubMed ID: 25117714
[TBL] [Abstract][Full Text] [Related]
15. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response.
Bao S; Wu Q; McLendon RE; Hao Y; Shi Q; Hjelmeland AB; Dewhirst MW; Bigner DD; Rich JN
Nature; 2006 Dec; 444(7120):756-60. PubMed ID: 17051156
[TBL] [Abstract][Full Text] [Related]
16. Intrinsic gene expression profiles of gliomas are a better predictor of survival than histology.
Gravendeel LA; Kouwenhoven MC; Gevaert O; de Rooi JJ; Stubbs AP; Duijm JE; Daemen A; Bleeker FE; Bralten LB; Kloosterhof NK; De Moor B; Eilers PH; van der Spek PJ; Kros JM; Sillevis Smitt PA; van den Bent MJ; French PJ
Cancer Res; 2009 Dec; 69(23):9065-72. PubMed ID: 19920198
[TBL] [Abstract][Full Text] [Related]
17. Mesenchymal glioma stem cells are maintained by activated glycolytic metabolism involving aldehyde dehydrogenase 1A3.
Mao P; Joshi K; Li J; Kim SH; Li P; Santana-Santos L; Luthra S; Chandran UR; Benos PV; Smith L; Wang M; Hu B; Cheng SY; Sobol RW; Nakano I
Proc Natl Acad Sci U S A; 2013 May; 110(21):8644-9. PubMed ID: 23650391
[TBL] [Abstract][Full Text] [Related]
18. The transcriptional network for mesenchymal transformation of brain tumours.
Carro MS; Lim WK; Alvarez MJ; Bollo RJ; Zhao X; Snyder EY; Sulman EP; Anne SL; Doetsch F; Colman H; Lasorella A; Aldape K; Califano A; Iavarone A
Nature; 2010 Jan; 463(7279):318-25. PubMed ID: 20032975
[TBL] [Abstract][Full Text] [Related]
19. Tumor Evolution of Glioma-Intrinsic Gene Expression Subtypes Associates with Immunological Changes in the Microenvironment.
Wang Q; Hu B; Hu X; Kim H; Squatrito M; Scarpace L; deCarvalho AC; Lyu S; Li P; Li Y; Barthel F; Cho HJ; Lin YH; Satani N; Martinez-Ledesma E; Zheng S; Chang E; Sauvé CG; Olar A; Lan ZD; Finocchiaro G; Phillips JJ; Berger MS; Gabrusiewicz KR; Wang G; Eskilsson E; Hu J; Mikkelsen T; DePinho RA; Muller F; Heimberger AB; Sulman EP; Nam DH; Verhaak RGW
Cancer Cell; 2017 Jul; 32(1):42-56.e6. PubMed ID: 28697342
[TBL] [Abstract][Full Text] [Related]
20. Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma.
Ceccarelli M; Barthel FP; Malta TM; Sabedot TS; Salama SR; Murray BA; Morozova O; Newton Y; Radenbaugh A; Pagnotta SM; Anjum S; Wang J; Manyam G; Zoppoli P; Ling S; Rao AA; Grifford M; Cherniack AD; Zhang H; Poisson L; Carlotti CG; Tirapelli DP; Rao A; Mikkelsen T; Lau CC; Yung WK; Rabadan R; Huse J; Brat DJ; Lehman NL; Barnholtz-Sloan JS; Zheng S; Hess K; Rao G; Meyerson M; Beroukhim R; Cooper L; Akbani R; Wrensch M; Haussler D; Aldape KD; Laird PW; Gutmann DH; ; Noushmehr H; Iavarone A; Verhaak RG
Cell; 2016 Jan; 164(3):550-63. PubMed ID: 26824661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
